Stéphane Ferretti

4.5k total citations
32 papers, 1.4k citations indexed

About

Stéphane Ferretti is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Stéphane Ferretti has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Stéphane Ferretti's work include Cancer-related Molecular Pathways (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Microtubule and mitosis dynamics (5 papers). Stéphane Ferretti is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Microtubule and mitosis dynamics (5 papers). Stéphane Ferretti collaborates with scholars based in Switzerland, United States and Singapore. Stéphane Ferretti's co-authors include Alexandre Trifilieff, Olivier Bonneau, Carol E. Jones, Gerald Dubois, Paul M.J. McSheehy, Peter R. Allegrini, Patrick Chêne, Marta Cortés-Cros, Stephan Ruetz and Pascal Furet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Immunology.

In The Last Decade

Stéphane Ferretti

32 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stéphane Ferretti Switzerland	18	549	410	373	259	180	32	1.4k
Sachi Horibata United States	16	838 1.5×	477 1.2×	550 1.5×	281 1.1×	123 0.7×	31	1.6k
Alfredo A. Molinolo United States	20	672 1.2×	562 1.4×	188 0.5×	293 1.1×	107 0.6×	30	1.6k
Mohamed H. Abdel‐Rahman United States	24	943 1.7×	637 1.6×	406 1.1×	266 1.0×	324 1.8×	81	2.4k
Bruce Freimark United States	17	997 1.8×	458 1.1×	785 2.1×	334 1.3×	240 1.3×	43	2.1k
Nicolaas H. C. Brons Luxembourg	25	701 1.3×	566 1.4×	691 1.9×	239 0.9×	136 0.8×	56	2.1k
J M Arbeit United States	14	601 1.1×	457 1.1×	258 0.7×	368 1.4×	174 1.0×	21	1.6k
Niels Bovenschen Netherlands	29	945 1.7×	531 1.3×	1.1k 2.8×	247 1.0×	114 0.6×	83	2.7k
Andrea Kristina Horst Germany	21	605 1.1×	409 1.0×	525 1.4×	110 0.4×	92 0.5×	35	1.7k
Hongxiu Ji United States	17	440 0.8×	267 0.7×	411 1.1×	149 0.6×	140 0.8×	42	1.4k
Junho Chung South Korea	24	939 1.7×	406 1.0×	310 0.8×	143 0.6×	101 0.6×	99	1.8k

Countries citing papers authored by Stéphane Ferretti

Since Specialization

Citations

This map shows the geographic impact of Stéphane Ferretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Ferretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Ferretti more than expected).

Fields of papers citing papers by Stéphane Ferretti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Ferretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Ferretti. The network helps show where Stéphane Ferretti may publish in the future.

Co-authorship network of co-authors of Stéphane Ferretti

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Ferretti. A scholar is included among the top collaborators of Stéphane Ferretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Ferretti. Stéphane Ferretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moschetta, Michele, Toshihiko Doi, Yasutoshi Kuboki, et al.. (2023). 719TiP A phase I/Ib study of the Werner (WRN) helicase inhibitor HRO761 as single agent and in combination with irinotecan or tislelizumab in patients with microsatellite instability-high (MSIhi) or mismatch repair deficient (dMMR) advanced solid tumors. Annals of Oncology. 34. S496–S496. 1 indexed citations

Israël, Laura, Anton Glück, Kea Martin, et al.. (2021). CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo. Oncogenesis. 10(4). 32–32. 10 indexed citations

Bégué, Damien, Valentina Cordo’, Gráinne Kerr, et al.. (2021). Therapeutic Assessment of Targeting ASNS Combined with l -Asparaginase Treatment in Solid Tumors and Investigation of Resistance Mechanisms. ACS Pharmacology & Translational Science. 4(1). 327–337. 18 indexed citations

Razak, Albiruni R. Abdul, Sebastian Bauer, Cristina Suárez, et al.. (2021). Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study. Clinical Cancer Research. 28(6). 1087–1097. 43 indexed citations

Bauer, Sebastian, George D. Demetri, Ensar Halilovic, et al.. (2021). Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies. British Journal of Cancer. 125(5). 687–698. 25 indexed citations

Guerreiro, Nelson, Astrid Jullion, Stéphane Ferretti, Claire Fabre, & Christophe Meille. (2021). Translational Modeling of Anticancer Efficacy to Predict Clinical Outcomes in a First-in-Human Phase 1 Study of MDM2 Inhibitor HDM201. The AAPS Journal. 23(2). 28–28. 14 indexed citations

Stewart-Ornstein, Jacob, Yoshiko Iwamoto, Miles A. Miller, et al.. (2021). p53 dynamics vary between tissues and are linked with radiation sensitivity. Nature Communications. 12(1). 898–898. 54 indexed citations

Sprouffske, Kathleen, Gráinne Kerr, Anirudh Prahallad, et al.. (2020). Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft models. Computational and Structural Biotechnology Journal. 18. 323–331. 21 indexed citations

Park, Donglim Esther, Jingwei Cheng, Christian Berrios, et al.. (2018). Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response. Proceedings of the National Academy of Sciences. 116(3). 1027–1032. 69 indexed citations

10.

Vaupel, Andrea, Philipp Holzer, Stéphane Ferretti, et al.. (2018). In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor. Bioorganic & Medicinal Chemistry Letters. 28(20). 3404–3408. 16 indexed citations

11.

Horn, Thomas, Stéphane Ferretti, Nicolas Ebel, et al.. (2016). High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells. Cancer Research. 76(23). 6950–6963. 24 indexed citations

12.

Holzer, Philipp, Keiichi Masuya, Pascal Furet, et al.. (2015). Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors. Journal of Medicinal Chemistry. 58(16). 6348–6358. 152 indexed citations

13.

Weidensteiner, Claudia, et al.. (2014). Tumour T1 changes in vivo are highly predictive of response to chemotherapy and reflect the number of viable tumour cells – a preclinical MR study in mice. BMC Cancer. 14(1). 88–88. 24 indexed citations

14.

McSheehy, Paul M.J., Claudia Weidensteiner, Catherine Cannet, et al.. (2009). Quantified Tumor T1 Is a Generic Early-Response Imaging Biomarker for Chemotherapy Reflecting Cell Viability. Clinical Cancer Research. 16(1). 212–225. 47 indexed citations

15.

Ebenhan, Thomas, M. Honer, Simon M. Ametamey, et al.. (2009). Comparison of [18F]-Tracers in Various Experimental Tumor Models by PET Imaging and Identification of an Early Response Biomarker for the Novel Microtubule Stabilizer Patupilone. Molecular Imaging and Biology. 11(5). 308–321. 21 indexed citations

16.

McSheehy, Paul M.J., Peter R. Allegrini, Thomas Ebenhan, et al.. (2008). Minimally Invasive Biomarkers for Therapy Monitoring. PubMed. 153–188. 4 indexed citations

17.

Bonneau, Olivier, et al.. (2005). Effect of adenosine A_2Areceptor activation in murine models of respiratory disorders. American Journal of Physiology-Lung Cellular and Molecular Physiology. 290(5). L1036–L1043. 54 indexed citations

18.

O’Reilly, Terry, Markus Wartmann, Saveur-Michel Maira, et al.. (2004). Patupilone (epothilone B, EPO906) and imatinib (STI571, Glivec) in combination display enhanced antitumour activity in vivo against experimental rat C6 glioma. Cancer Chemotherapy and Pharmacology. 55(4). 307–317. 24 indexed citations

19.

Ferretti, Stéphane, Olivier Bonneau, Gerald Dubois, Carol E. Jones, & Alexandre Trifilieff. (2003). IL-17, Produced by Lymphocytes and Neutrophils, Is Necessary for Lipopolysaccharide-Induced Airway Neutrophilia: IL-15 as a Possible Trigger. The Journal of Immunology. 170(4). 2106–2112. 448 indexed citations

20.

Corteling, Randolph, et al.. (2003). Differential DNA synthesis in response to activation of protease-activated receptors on cultured guinea-pig tracheal smooth muscle cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 368(1). 10–16. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact